EUVIMEDEUVIMED entdecken
Crossref

A Redox‐Responsive Nanoplatform Modulating the Treg/Th17 Balance Through LAT1‐ and PPARγ‐Related Pathways for Psoriasis Therapy

Xinyu Jiang, Yingyi Zhao, Zihao Huang, Yuqi Han, Zihao Tao, Belquis Dakhane iD, Yinhao Lin, Dingchao Shen, Yanxian Hou, Shisheng Chen iD, Qing Yao iD, Helin Xu iD und 2 weitere

Small · 2026

DOI: 10.1002/smll.75126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2026. Verfasst von Xinyu Jiang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Wenzhou Municipal Key Laboratory of Pediatric Pharmacy, Department of Pharmacy, The Second Affiliated Hospital and Yuying Children's Hospital of Wenz…. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Psoriasis, Th17 Cells, Nanoparticles. Die Arbeit nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Zhejiang Medical and Health Technology Plan, Hospital Pharmacy Special Project of Zhejiang Pharmaceutical Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriasis is a chronic autoimmune skin disease affecting 2%–3% of the global population. Existing therapies, including topical agents, systemic immunosuppressants, and phototherapy, often suffer from limited efficacy, skin irritation, or serious side effects, highlighting the urgent need for more effective and safer alternatives. Notably, restoring the dynamic balance between regulatory T (Treg) cells and T helper 17 (Th17) cells has emerged as a promising strategy for halting psoriatic progression. Here, we developed a redox‐responsive nanoparticle‐based topical hydrogel, PB‐MJ@N/G, that co‐delivers morin (a natural PPARγ activator that promotes Treg proliferation) and JPH203 (a LAT1 inhibitor that suppresses Th17 cell expansion) to modulate the Treg/Th17 balance in psoriatic skin. These drugs were co‐loaded into PLA nanoparticles and further coated with bilirubin‐conjugated poly‐L‐lysine (PB), enabling surface charge reversal and promoting local skin association and nanoparticle‐associated delivery into psoriatic skin. In response to the oxidative microenvironment, oxidation‐associated changes in the bilirubin‐containing PB coating increased its hydrophilicity and facilitated accelerated local drug release. In both in vitro and in vivo models, PB‐MJ@N significantly restored the Treg/Th17 ratio, alleviated psoriatic inflammation, and attenuated relapse‐associated lesion development in a recurrence model. This topical, stimuli‐responsive nanoparticle presents a powerful immunotherapeutic strategy for psoriasis, supporting sustained treatment‐associated benefit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Lymphocytes, RegulatoryPsoriasisTh17 CellsNanoparticlesPPAR gammaAnimalsOxidation-ReductionHumansMiceSignal Transduction

Stichwörter der Autor:innen

JPH203LAT1 inhibitionTreg/Th17 balanceimmune homeostasismorinpsoriasistransdermal delivery

Substanzen

PPAR gamma

Autor:innen und Institutionen

  • Wenzhou Municipal Key Laboratory of Pediatric Pharmacy, Department of Pharmacy, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
  • Department of Pharmaceutics, School of Pharmacy, Ningxia Medical University, Yinchuan, China.
  • School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
  • Department of Dermatology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.

ORCID-Profile: Belquis Dakhane, Shisheng Chen, Qing Yao, Helin Xu, Longfa Kou

Förderung

  • National Natural Science Foundation of China
  • Zhejiang Medical and Health Technology Plan
  • Hospital Pharmacy Special Project of Zhejiang Pharmaceutical Association
  • Wenzhou Municipal Science and Technology Bureau

Zitieren

APA

Jiang, X., Zhao, Y., Huang, Z., Han, Y., Tao, Z., Dakhane, B., Lin, Y., Shen, D., Hou, Y., Chen, S., Yao, Q., Xu, H., Chen, R., & Kou, L. (2026). A Redox‐Responsive Nanoplatform Modulating the Treg/Th17 Balance Through LAT1‐ and PPARγ‐Related Pathways for Psoriasis Therapy. Small. https://doi.org/10.1002/smll.75126

Vancouver

Jiang X, Zhao Y, Huang Z, Han Y, Tao Z, Dakhane B, et al. A Redox‐Responsive Nanoplatform Modulating the Treg/Th17 Balance Through LAT1‐ and PPARγ‐Related Pathways for Psoriasis Therapy. Small. 2026. doi:10.1002/smll.75126

BibTeX
@article{Jiang2026,
  author = {Jiang, Xinyu and Zhao, Yingyi and Huang, Zihao and Han, Yuqi and Tao, Zihao and Dakhane, Belquis and Lin, Yinhao and Shen, Dingchao and Hou, Yanxian and Chen, Shisheng and Yao, Qing and Xu, Helin and Chen, Ruijie and Kou, Longfa},
  title = {A Redox‐Responsive Nanoplatform Modulating the Treg/Th17 Balance Through LAT1‐ and PPARγ‐Related Pathways for Psoriasis Therapy},
  journal = {Small},
  year = {2026},
  doi = {10.1002/smll.75126}
}
Kostenlos starten →